Author

Antonio Pisani

Federico II University HospitalPrimary ORCID profile (0000-0002-8432-594X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Antonio PisaniiD1 paper · University of Rome Tor Vergata

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alessandro VitiiD· 1 shared Antonella Fiordelisi· 1 shared Antonietta Buonaiuto· 1 shared Antonio BiancoiD· 1 shared Antonio PezoneiD· 1 shared Cinzia PerrinoiD· 1 shared Daniela SorrientoiD· 1 shared Eduardo SommellaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Alessandro VitiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart

Jessica Gambardella, Antonella Fiordelisi, Federica Andrea Cerasuolo, Antonietta Buonaiuto, Roberta Avvisato, Alessandro Viti, Eduardo Sommella, Pietro Campiglia, Valeria D’Argenio, Nella Prevete, Antonio Pezone, Stefania D’Apice, Giovanna Giuseppina Altobelli, Fahimeh Varzideh, Shivangi Pande, , Guido Iaccarino

This study identifies mitochondrial dysfunction and impaired mitophagy as key drivers of cardiac damage in Fabry disease and shows that L-arginine supplementation can prevent cardiac abnormalities.

Cell Reports · Oct 26, 2026Peer-reviewedPathology